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Introduction 
First reports on a pancreatic transplantation by Minkowsk i [1] , who performed 
an autologous pancreatic transplantation to the abdominal walls o f a dog, date 
back to the year 1891. I n 1966, Kelly [2] succeeded in performing the first vascular 
pancreatic transplantation in human. This transplantation was preceded by 
experimental islet cell transplantations attempting to influence diabetes mellitus 
either in a curative or a preventive way. In the 1970s, clinical pancreatic 
transplantation became common in a variety of different surgical techniques, all 
having the same diff icul ty, namely, managing the exocrine part o f the gland. I n 
spite o f new surgical techniques, this problem, which can cause both early and 
long-term complications, has still not been adequately solved. To eliminate the 
exocrine part o f the gland, duct occlusion, as well as enteric drainage and bladder 
drainage, is used at present. 
The main topic o f this report is our experience gained wi th prolamine in duct 
occlusion in segmental pancreatic transplantation and what is probably its most 
frequent surgical complicat ion: the pancreatic fistula. I n addi t ion, the occurrence 
of pancreatic fistulas when using bladder drainage or enteric diversion is 
described here. 
Effects of Prolamine 
The properties o f the quick-hardening, alcoholic amino acid solution (Eth i -
bloc), are described in experimental studies by Gebhardt and Stolte [3, 4] . The 
injection o f this solution into the pancreatic duct leads to necrosis and in the 
further course to atrophy of the excretory parenchyma and the format ion o f 
an interstitial fibrosis, which starts on the 11th day after injection and is 
completed between the 50th and 60th day wi th a total extinction o f the 
exocrine part o f the parenchyma. The islet cell apparatus remains unimpaired 
by the structural alterations. Experiences gained wi th this substance in clinical 
pancreatic transplantation are somewhat different [5] . In contrast to animal 
experimental findings, in this case a clearly retarded atrophy and destruction 
o f the excretory parenchyma can be observed. The result is a temporary 
remaining function of the excretory apparatus wi th variable durat ion, which 
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is, according to our observations, a m i n i m u m of 2 months and a maximum of 
18 months. 
As a result o f this temporary remaining function the two fol lowing major 
complications occur: 
1. Transcutaneous pancreatic fistula 
2. Peripancreatic f lu id collection, which manifests itself as pseudocyst 
Patients and Methods 
Between 1979 and 1989 a total of 102 pancreatic transplantations wi th duct 
occlusion using Ethibloc were performed at our center. In 90 patients simul-
taneous pancreatic and kidney transplantation was performed. Five patients 
received a pancreatic regraft and seven patients a pancreas alone. 
The technique of duct occlusion ex vivo has been described elsewhere [6] . In 
every case duct occlusion wi th Ethibloc was performed in a segmental pancreatic 
allograft consisting o f body and tai l . There were several modifications in surgical 
technique and postoperative management dur ing the period mentioned. Only the 
modifications concerning surgical technique are described here [7, 8]. 
Group I {n = 29). 
Duct occlusion was with prolamine in a segmental pancreatic allograft. Placement 
of the pancreatic graft was part ial ly extra-, part ial ly intraperitoneal, orginally 
described by Dubcrnard [9] . 
Group II(n = l). 
Duct occlusion was wi th prolamine. Placement of the graft was intraperitoneal 
along the colon ascendens. Drainage o f the abdominal cavity was for 2 days only. 
Group III (n = 2%). 
Duct occlusion was wi th prolamine. Placement o f the graft was strictly 
intraperitoneal wi th continuous intraabdominal lavage for a short period (2-3 
days). 
Group IV (n 38). 
Duct occlusion was wi th prolamine. Placement of the pancreatic graft was strictly 
intraperitoneal. Continuous lavage plus tissue adhesive was performed. 
Occurrence of Pancreatic Fistulas 
and Peripancreatic Pseudocysts 
I n total we observed a pancreatic fistula in 33 (32%) out o f 102 duct-occluded 
pancreatic grafts. Five (5%) out o f 102 duct-occluded pancreatic allografts 
developed a peripancreatic f lu id collection like a pseudocyst. The pancreatic 
fistula manifests itself in the 2 or 3 week after transplantation. The formation o f 
pseudocysts, however, occurs 1 or 2 months posttransplant. 
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Table 1. Incidence of pancreatic fistulas according to different surgical technique 
Surgical technique: Fistulas Pseudo- G i aft loss 
positioning of the graft cysts fol 
fis 
lowing 
ula 
Extra-/intraperitoncally (n 29) n- 10 n - 3 n 6 
(34%) 
Intraperitoneal!)'" (n 1) (n 3 - n 2 
(42%) 
Intraperitoneally n = 9 n 1 n 3 
plus continuous lavage (n 28) (32%) 
Intraperitoneally lavage n - 11 n 1 n 5 
plus tissue adhesive (n 38) (29%) 
Occurrence of Pancreatic Fistula 
with Different Surgical Techniques 
In the early phase o f the method with partially extra-, part ial ly intraperitoneal 
placement of the allograft, almost every second patient developed a pancreatic 
fistula. A n d even modifying the surgical technique to strictly intraperitoneal 
placement of the graft and temporary peritoneal lavage, the incidence o f 
pancreatic fistulas was not significantly reduced [10]. The application o f a f ibr in 
adhesive, the properties o f which are known from general surgery, to the surface 
of the parenchyma, at first showed promising results concerning a reduction in 
pancreatic fistulas. However, considering all the clinical cases in which the duct 
occlusion technique has been performed, no statistical difference in fistula 
incidence rate is observed, whatever surgical technique was applied (Table 1). Of 
note is a group of patients (n =- 7), in whom the graft was placed intraperitoneally 
but who did not receive short-term lavage and instead had the peritoneal cavity 
drained for only 2 days. In these patients the remaining exocrine segregation o f the 
gland caused serious complications (adhesive ileus); therefore, we abandoned this 
technique. 
Pathogenesis of a Pancreatic Fistula When Using Prolamine 
The pathogenesis o f a pancreatic fistula is not uniform and furthermore has not 
been completely clarified. However, the procreation o f an edema which allows the 
enzymes to be secreted directly from the parenchyma has to be ascribed mainly to 
prolamine, since the duct system is more or less filled wi th occlusion substance. 
The structural alterations in the gland caused by prolamines, which finally cause 
the destruction of the exocrine apparatus, also allow the enzymes to be secreted 
from the parenchyma. Since these processes, in contrast to animal experimental 
data gathered by Gebhardt and Stolte, proceed wi th delay and lead to retarded 
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destruction of the exocrine apparatus, a temporary excretory active gland results. 
The coincidence of incomplete wound healing and remaining excretory function 
cause the secretions to form a pancreatic fistula on the skin surface. If, however, 
the wound healing is complete, the remaining secretion manifests itself as a 
pancreatic pseudocyst. It is unclear why the prolamine technique does not result 
in the gland retaining some function in every case. Therefore, other factors which 
can cause pancreatic edema have to be considered: traumatic pancreatitis, 
ischemia, perfusion injury, reperfusion injury, and immunological processes. This 
is the only explanation for the fact that for drainage technique peripancrcatic f lu id 
collections also need to be considered [11], although in this case the enzymes are 
led into the intestines or the bladder. 
Is Prevention of Pancreatic Fistulas Possible? 
The surgical modifications described and the introduct ion o f f ibr in adhesiv were 
intended to prevent or reduce the formation of a pancreatic fistula. W i t h the 
intraperitoneal placement of the pancreatic graft and short-term peritoneal lavage 
we hoped on the one hand to take advantage of the resorption capacity o f the 
peritoneum; on the other hand, we aimed to eliminate the enzymes which are, 
especially in the early postoperative phase, detectable in the abdominal cavity 
[12]. By these means we aimed to achieve undisturbed wound healing. Further-
more we achieved suppression of the exocrine apparatus wi th routine administrat-
ion of somatostatin over a period o f 10 days. A t present it can be stated that none 
of the modifications applied in recent years have significantly reduced the 
incidence of pancreatic fistula. 
Surgical Complications Following Pancreatic Fistula 
Table 2 shows the complications fol lowing pancreatic fistula, the main one being 
secondary infection, which we refer to below as complicated pancreatic fistula. In 
the majority o f cases (53%), an infection with Staphylococcus aureus was 
demonstrable. In the remaining infection, Pseudomonas, Escherichia coli, and 
Candida organisms were identified. 
Table 2. Surgical complications fol lowing pancreatic fistula 
1. Secondary infection with peripancrcatic abscess n 31 
2. Adhesive ileus n - 5 
3. Small bowel fistula n - 1 
4. Pcricholecystic abscess n - 2 
5. Burst abdomen n 1 
6. Erosion bleeding n 9 
7. Patient's death n 3 
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Strategies of Treatment of Pancreatic Fistulas 
Conservative Treatment 
In contrast to reports by the Oslo group, we observed no spontaneous fistula 
healing [ 13]. Suppression o f exocrine secretion wi th somatostatin and its analogue 
SMS or wi th other drugs is helpful [14, 15]. In our experience complete 
interruption of fistulation wi th conservative treatment could not be achieved. 
Surgical-Conservative Treatment (Table 3) 
Almost all transcutaneous pancreatic fistulas developed a secondary infection 
and a peripancreatic abscess at the same time. It should also be mentioned that the 
secretions of the pancreas represent an ideal nutrit ive medium for bacteria and 
fungi. The pr imary aim o f the treatment has to be the application of sanitary 
measures to the infection in connection wi th a reduction of pancreatic secretion in 
the wound area. I n addi t ion, local or systematic antibiosis and suppression of the 
excretory gland wi th somatostatin is helpful. Because of the different placements 
of the pancreatic graft we used both extraperitoneal placement drainage and open 
wound treatment, the latter being more successful. When the pancreas was placed 
intraperitoneally, peritoneal lavage was applied for 1-3 weeks unt i l sterility was 
achieved. I f necessary, this procedure had to be repeated two or three times. 
I f the peritoneal lavage is not successful, either programmed or open wound 
treatment has to be applied. Our experience has shown that peritoneal lavage is 
conncccted wi th the lowest rate o f graft loss, although this treatment is more time-
consuming than other methods of treatment. Treatment o f a pseudocyst wi th 
repeated puncture causes no problems. I n 16 patients (48%) who had developed a 
complicated fistula these therapeutic measures failed, resulting in removal of the 
graft. 
Two examples of complicated pancreatic fistulas are described: 
Case 1. This patient had an extremely long lasting pancreatic secretion, which led 
to the formation o f a pseudocyst. After repeated puncture 18 months posttrans-
plant he developed an acute abdomen with tentative diagnosis of a peripancreatic 
abscess. This necessitated surgical intervention, whereby two small holes in the 
Table 3. Success rate of surgical treatment fol lowing pancreatic fistulas 
Treatment Success rate 
Drainage 
Peritoneal lavage 
Programmed peritoneal lavage 
Open wound treatment 
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pancreatic parenchyma were detected, which maintained the secretions. To what 
extent these minor injuries were caused by the repeated puncture could not be 
clarified. The holes or defects in the pancreatic parenchyma closed only by open 
wound treatment in combinat ion with granulation processes. 
Case 2. In this patient a complicated pancreatic fistula wi th Candida organisms led 
to arterial erosion bleeding. First the rupture on the arterial donor patch was 
sutured. Ligat ion of the arteria iliaca externa proved lifesaving when there was 
recurrent bleeding. Thereafter, the patient developed thrombosis o f the arteria 
poplitea, which could not be treated successfully either by thrombectomy or by-
local lysis. Gangrene of the lower leg developed, which necessitated amputation o f 
the upper leg. 
Current Function Rate Following Pancreatic Fistula 
A t present 13 pancreatic grafts (40%) out o f 33 occluded organs, which had 
developed a pancreatic fistula, are functional. The pancreatic fistula does not 
influence endocrine function of the graft i n a negative way, either in the early or in 
the late phase. A l l 13 patients, who had a pancreatic fistula are free o f insulin and 
have a normal H b A ] level. 
Occurrence of Pancreatic Fistulas 
Using Neoprene for Duct Occlusion 
In his first series wi th extraperitoneal placement of the gland, Dubernard 
observed perigraft collections and local wound infections. He introduced 
"intraextraperitoneal" placement of the graft, performing a 4-cm peritoneal 
incision and an omentoplasty for drainage o f perigraft leakages [16]. Brekkc 
reported a fistula incidence of 30%-40% in a series in which the graft was placed 
partly intraperitoneally but the vessel anastomoses were carried out extraperito-
neally (13). When using this technique, the pancreatic fitulas healed spontaneous-
ly in most cases. 
Occurrence of Pancreatic Fistulas 
Using Enteric Exocrine Drainage 
The most physiological approach for treatment o f the exocrine secretion of the 
gland is a pancrea toenteros tomy to a jejunal Roux-loop, originally described by 
Gro th [17], or pancreaticoduodenal enterostomy in a jejunal Roux-loop, 
originally described by Liilehei [18]. However, the contamination o f the graft wi th 
the intestinal contents and the digestive forces of pancreatic juice are associated 
with a high incidence o f leakages and pancreatic fistulation. Wi th some 
modifications of this technique, the Stockholm group reduced the incidence of 
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pancreatic fistulas. These modifications included intraperitoneal placement of the 
pancreatic graft and pancreatic duct drainage with a catheter to the exterior for a 
short period [19]. Sutherland and Hesse report intraabdominal f luid collections 
after pancreatic transplantation [20]. They aggree with our observation that the 
fluid produced by the pancreatic graft provides an good medium for infection. 
These intraabdominal infections are associated wi th a high rate of mortal i ty and 
morbid i ty . 
Occurrence of Pancreatic Fistulas 
Using the Bladder Drainage Technique 
Sollinger and Corry perfomed organ procurement wi thout traumatizing the 
pancreas and careful l igation o f the peripancreatic lymphatics to prevent 
traumatic pancreatitis and subsequent lymphatic fistula in the recipient. Sollinger 
noted a causal connection between wound infection incidence and the type o f 
wound incision dur ing surgery. He changed from an oblique incision to a midline 
incision and concluded that the incision should be as distant f rom the pancreatic 
graft as possible to avoid dissection of lymphatics and exocrine pancreatic f luid 
penetration through the wound [21]. Corry placed the pancreatic graft extraperit-
oncally but opened the peritoneum widely to permit any surface drainage from the 
pancreas to be absorbed intraperitoneally. When using this procedure no 
pancreatic fistulas were observed in a series o f 24 patients [22]. 
Conclusions 
Pancreatic fistula after duct occlusion wi th prolamine in 32% o f patients 
represents a high complicat ion rate. Our data are comparable w i th data reported 
by Brekke in the early phase of the use o f neoprene for duct obli terat ion. 
Nevertheless, 40%; of fistulas can be successfully cured wi th surgical treatment in 
our experience. I n contrast to the data reported by the Oslo group we did not 
observe spontaneous fistula healing. Using our technique, the pancreatic fistula is 
assosicated wi th a high rate o f morbid i ty but it does not lead to deterioration of 
the graft. I n spite of various surgical modifications, incidence o f pancreatic 
fistulas could not be prevented or reduced. Our observations differ from the 
observations o f other groups, who also modified their surgical technique. They 
report possible reduction of fistulation by intraperitoneal placement o f the 
pancreas and by drainage o f pancreatic enzymes through an incision of the 
peritoneum when placing the pancreas extraperi toneal^. Al though different 
surgical techniques were applied, all groups confirm the risk o f f lu id collection 
produced by the pancreatic graft, even when the bladder or intestine is used for 
exocrine diversion. The surgical treatment o f a complicated pancreatic fistula, 
however, is diff icult , is time-consuming and can provoke further complications. 
The addit ional treatment wi th somatostatin, SMS, and other drugs is 
helpful, but surely not sufficient alone. Because of the simplicity of the duct 
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occlusion technique in pancreatic transplantation our group wi l l undertake 
further studies to develop a more potent occlusion substance with a lower 
complication rate. 
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